Patient groups cheer as the WHO adds diabetes and cystic fibrosis drugs to its essential medicines list Advocates hope the move will usher in a new era of accessibility for low- and middle-income countries

https://www.statnews.com/pharmalot/2025/09/05/who-medicines-pharma-biotech-diabetes-obesity-cystic-fibrosis-vertex-lilly-novo-sanofi/